Royalty Pharma PLC (NASDAQ:RPRX)
| 41.27 Delayed Data As of May 27 |  +1.26 / +3.15%Today’s Change | 34.86 Today|||52-Week Range 47.10 | +3.56% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
New Ventures Llc /venture Capital/ Director |  Sale | 6/25/2021 | 487,364 | $42.69 | $20.8M | -3.08% |
New Ventures Llc /venture Capital/ Director | Sale | 6/29/2021 | 479,800 | $41.26 | $19.8M | +0.34% |
New Ventures Llc /venture Capital/ Director | Sale | 6/07/2021 | 273,650 | $45.26 | $12.4M | -11.17% |
New Ventures Llc /venture Capital/ Director | Sale | 6/25/2021 | 179,100 | $42.81 | $7.7M | -3.08% |
New Ventures Llc /venture Capital/ Director | Sale | 6/28/2021 | 167,448 | $42.11 | $7.1M | -1.50% |
Riggs Rory Balfour Director | Sale | 5/20/2022 | 123,696 | $39.28 | $4.9M | +4.43% |
Reddoch James F | Sale | 6/04/2021 | 100,000 | $44.60 | $4.5M | -8.71% |
Lloyd George /royalty/ | Sale | 5/23/2022 | 100,000 | $40.27 | $4.0M | +3.05% |
Lloyd George /royalty/ | Sale | 11/17/2021 | 84,148 | $42.39 | $3.6M | -2.85% |
Lloyd George /royalty/ | Sale | 11/16/2021 | 72,659 | $42.33 | $3.1M | -1.71% |
Page of 9